Nature Communications (Feb 2021)
Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer
Abstract
Precise control of immune response remains challenging for cancer immunotherapy. Here, the authors report on photothermally activatable semiconducting polymeric pro-agonist in response to second near-infrared window light for regulated photothermal immunotherapy.